HCW Biologics Inc.
HCWB
$7.05
-$0.58-7.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.37M | -3.90M | -15.28M | -7.47M | -10.68M |
| Total Depreciation and Amortization | 682.50K | 128.40K | 129.90K | 243.50K | 274.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 292.10K | 232.40K | 239.80K | 244.30K | 5.51M |
| Change in Net Operating Assets | -436.20K | 614.90K | 10.05M | 3.38M | 1.00M |
| Cash from Operations | -2.83M | -2.93M | -4.86M | -3.60M | -3.89M |
| Capital Expenditure | -113.40K | -37.10K | 18.60K | -129.70K | -3.72M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -113.40K | -37.10K | 18.60K | -129.70K | -3.72M |
| Total Debt Issued | 375.00K | 2.83M | 1.95M | 1.75M | -- |
| Total Debt Repaid | -31.00K | -29.60K | -29.10K | -29.70K | -29.30K |
| Issuance of Common Stock | 6.92M | 0.00 | 0.00 | 2.50M | 14.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -638.00K | -- | -- | -- | -- |
| Cash from Financing | 6.62M | 2.80M | 1.92M | 4.22M | -15.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.68M | -163.10K | -2.92M | 489.00K | -7.63M |